210 related articles for article (PubMed ID: 26072310)
1. Broad range of inhibiting action of novel camphor-based compound with anti-hemagglutinin activity against influenza viruses in vitro and in vivo.
Zarubaev VV; Garshinina AV; Tretiak TS; Fedorova VA; Shtro AA; Sokolova AS; Yarovaya OI; Salakhutdinov NF
Antiviral Res; 2015 Aug; 120():126-33. PubMed ID: 26072310
[TBL] [Abstract][Full Text] [Related]
2. Selection of influenza virus resistant to the novel camphor-based antiviral camphecene results in loss of pathogenicity.
Zarubaev VV; Pushkina EA; Borisevich SS; Galochkina AV; Garshinina AV; Shtro AA; Egorova AA; Sokolova AS; Khursan SL; Yarovaya OI; Salakhutdinov NF
Virology; 2018 Nov; 524():69-77. PubMed ID: 30165308
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of novel camphecene analogues as anti-influenza agents.
Yarovaya OI; Sokolova AS; Mainagashev IY; Volobueva AS; Lantseva K; Borisevich SS; Shtro AA; Zarubaev VV; Salakhutdinov NF
Bioorg Med Chem Lett; 2019 Dec; 29(23):126745. PubMed ID: 31668423
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of Camphecene and Cytisine Conjugates Using Click Chemistry Methodology and Study of Their Antiviral Activity.
Artyushin OI; Moiseeva AA; Zarubaev VV; Slita AV; Galochkina AV; Muryleva AA; Borisevich SS; Yarovaya OI; Salakhutdinov NF; Brel VK
Chem Biodivers; 2019 Nov; 16(11):e1900340. PubMed ID: 31647170
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of influenza virus replication by plant-derived isoquercetin.
Kim Y; Narayanan S; Chang KO
Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
[TBL] [Abstract][Full Text] [Related]
6. Optimization of application schedule of camphecene, a novel anti-influenza compound, based on its pharmacokinetic characteristics.
Zarubaev VV; Garshinina AV; Volobueva AS; Slita AV; Yarovaya OI; Bykov VV; Leonov KA; Motov VS; Khazanov VA; Salakhutdinov NF
Fundam Clin Pharmacol; 2022 Jun; 36(3):518-525. PubMed ID: 34984730
[TBL] [Abstract][Full Text] [Related]
7. Antiviral Effects of Black Raspberry (Rubus coreanus) Seed and Its Gallic Acid against Influenza Virus Infection.
Lee JH; Oh M; Seok JH; Kim S; Lee DB; Bae G; Bae HI; Bae SY; Hong YM; Kwon SO; Lee DH; Song CS; Mun JY; Chung MS; Kim KH
Viruses; 2016 Jun; 8(6):. PubMed ID: 27275830
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of camphecene derivatives using click chemistry methodology and study of their antiviral activity.
Artyushin OI; Sharova EV; Vinogradova NM; Genkina GK; Moiseeva AA; Klemenkova ZS; Orshanskaya IR; Shtro AA; Kadyrova RA; Zarubaev VV; Yarovaya OI; Salakhutdinov NF; Brel VK
Bioorg Med Chem Lett; 2017 May; 27(10):2181-2184. PubMed ID: 28366530
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo influenza virus-inhibitory effects of viramidine.
Sidwell RW; Bailey KW; Wong MH; Barnard DL; Smee DF
Antiviral Res; 2005 Oct; 68(1):10-7. PubMed ID: 16087250
[TBL] [Abstract][Full Text] [Related]
10. Camphor-based symmetric diimines as inhibitors of influenza virus reproduction.
Sokolova AS; Yarovaya OC; Korchagina DV; Zarubaev VV; Tretiak TS; Anfimov PM; Kiselev OI; Salakhutdinov NF
Bioorg Med Chem; 2014 Apr; 22(7):2141-8. PubMed ID: 24631360
[TBL] [Abstract][Full Text] [Related]
11. Potent influenza A virus entry inhibitors targeting a conserved region of hemagglutinin.
Lin D; Luo Y; Yang G; Li F; Xie X; Chen D; He L; Wang J; Ye C; Lu S; Lv L; Liu S; He J
Biochem Pharmacol; 2017 Nov; 144():35-51. PubMed ID: 28774731
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of stachyflin on influenza A viruses of different hemagglutinin subtypes.
Motohashi Y; Igarashi M; Okamatsu M; Noshi T; Sakoda Y; Yamamoto N; Ito K; Yoshida R; Kida H
Virol J; 2013 Apr; 10():118. PubMed ID: 23587221
[TBL] [Abstract][Full Text] [Related]
13. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "Sho-seiryu-to"--effects on aged mice, against subtypes of a viruses and B virus, and therapeutic effect.
Nagai T; Urata M; Yamada H
Immunopharmacol Immunotoxicol; 1996 May; 18(2):193-208. PubMed ID: 8771367
[TBL] [Abstract][Full Text] [Related]
14. Can molecular dynamics explain decreased pathogenicity in mutant camphecene-resistant influenza virus?
Borisevich SS; Gureev MA; Yarovaya ОI; Zarubaev VV; Kostin GA; Porozov YB; Salakhutdinov NF
J Biomol Struct Dyn; 2022 Aug; 40(12):5481-5492. PubMed ID: 33480324
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of anti-influenza effects of camostat in mice infected with non-adapted human influenza viruses.
Lee MG; Kim KH; Park KY; Kim JS
Arch Virol; 1996; 141(10):1979-89. PubMed ID: 8920829
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Small Benzamide Inhibitor of Influenza Virus Using a Cell-Based Screening.
Shin WJ; Nam KY; Kim ND; Kim SH; No KT; Seong BL
Chemotherapy; 2016; 61(3):159-66. PubMed ID: 26821172
[TBL] [Abstract][Full Text] [Related]
17. Ethanol Extract of
Zhang L; Chen J; Ke C; Zhang H; Zhang S; Tang W; Liu C; Liu G; Chen S; Hu A; Sun W; Xiao Y; Liu M; Chen X
Viruses; 2020 May; 12(5):. PubMed ID: 32443510
[TBL] [Abstract][Full Text] [Related]
18. Effects of TheraMax on influenza virus infections in cell culture and in mice.
Smee DF; Hurst BL; Wong MH
Antivir Chem Chemother; 2011 Jul; 21(6):231-7. PubMed ID: 21730370
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus.
Zarubaev VV; Golod EL; Anfimov PM; Shtro AA; Saraev VV; Gavrilov AS; Logvinov AV; Kiselev OI
Bioorg Med Chem; 2010 Jan; 18(2):839-48. PubMed ID: 20006516
[TBL] [Abstract][Full Text] [Related]
20. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents.
Yu M; Liu A; Du G; Naesens L; Vanderlinden E; De Clercq E; Liu X
Chem Biol Drug Des; 2011 Oct; 78(4):596-602. PubMed ID: 21752202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
